Spero Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass. , March 22, 2018 (GLOBE NEWSWIRE) — Spero Therapeutics , Inc. (Nasdaq:SPRO), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections, announced today that Ankit

READ FULL TEXT

Leave a Reply

Your email address will not be published.